Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase follows, detailing how the body absorbs, distributes, metabolizes, and excretes the drug post-administration. This phase provides valuable insights into the physiological processing of drugs.
In the pharmacodynamic phase, the focus shifts to the drug's interaction with its target, which could be receptors, ion channels, enzymes, or transporters. This phase elucidates the relationship between drug concentration and its effect, shedding light on potential therapeutic or toxic impacts.
The final therapeutic phase translates these pharmacological effects into clinical outcomes. It assesses how the drug's interaction with the target—either by inhibiting or activating it—can alleviate disease symptoms. As a result, this comprehensive four-phase process ensures the development of efficacious and safe drugs.
Drugs are chemicals used for diagnosing, treating, or preventing diseases. The four phases of drug product preparation are pharmaceutic, pharmacokinetic, pharmacodynamic, and therapeutic phases.
The pharmaceutic phase focuses on the drug's physicochemical properties to design and manufacture a suitable product for effective administration. Examples include tablets or capsules for oral intake, creams or ointments for topical application, and solutions or emulsions for parenteral delivery.
Post-administration, the pharmacokinetic phase explains how the body processes the drug. It encompasses the drug's absorption, distribution, metabolism, and excretion in the body.
Upon reaching the site of action, the pharmacodynamic phase explains the drug's interaction with its target, such as receptors, ion channels, enzymes, or transporters. It helps study the relationship between the drug's concentration and its effect, whether therapeutic or toxic.
Lastly, the therapeutic phase translates pharmacological effects into clinical outcomes, that is, how the inhibition or activation of a target alleviates disease symptoms.